PDB24 COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINAXiaoxiang Hou, Baojun Wu, X. Wan et al.|Value in Health|2019Cited by 0